EX-99.1 2 ea187813ex99-1_incannex.htm ASX ANNOUNCEMENT, DATED NOVEMBER 07, 2023 - CHANGE OF DIRECTOR'S INTEREST X2

Exhibit 99.1

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Rule 3.19A.2

 

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

 

Introduced 30/09/01 Amended 01/01/11

 

Name of entity INCANNEX HEALTHCARE LIMTIED
ABN 93 096 635 246

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director Peter Widdows  
Date of last notice 6 June 2023

 

Part 1 - Change of director’s relevant interests in securities

 

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest Direct and indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

●    The Peter Widdows Superannuation Fund (Beneficiary)

●    Wealthhub Securities Noms P/L <JBWERE ACCUMULATION>

(Beneficiary)

Date of change 31 October 2023
No. and class of securities held prior to change

DIRECT 

●    15,973,694 IHL ordinary shares

●    1,064,913 unlisted $0.025 options expiring on 30 April 2026

 

INDIRECT 

●    600,000 IHL ordinary shares

●    40,000 unlisted $0.025 options expiring on 30 April 2026

Number acquired

DIRECT 

●    230,954 IHL ordinary shares

 

INDIRECT 

●    280,000 IHL ordinary shares

Number disposed

Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

 $33,842.10

 

+ See chapter 19 for defined terms. 
  
01/01/2011 Appendix 3Y  Page 1 

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

No. of securities held after change

DIRECT

 

●    16,204,648 IHL ordinary shares

●    1,064,913 unlisted $0.025 options expiring on 30 April 2026

 

INDIRECT

 

●    880,000 IHL ordinary shares

●    40,000 unlisted $0.025 options expiring on 30 April 2026

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 On Market Purchase

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract N/A
Nature of interest  

Name of registered holder

(if issued securities)

 

  
Date of change  

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

  
Interest acquired  
Interest disposed  

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

  
Interest after change  

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No.
If so, was prior written clearance provided to allow the trade to proceed during this period?  
If prior written clearance was provided, on what date was this provided?  

  

+ See chapter 19 for defined terms. 
  
Appendix 3Y  Page 201/01/2011

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Rule 3.19A.2

 

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

 

Introduced 30/09/01 Amended 01/01/11

 

Name of entity INCANNEX HEALTHCARE LIMTIED
ABN 93 096 635 246

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director Troy Valentine  
Date of last notice 6 June 2023

 

Part 1 - Change of director’s relevant interests in securities

 

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest Direct and indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

 See notes below
Date of change 3 November 2023
No. and class of securities held prior to change

●     36, 651 198 IHL Ordinary Shares

●     2,800,000 Options with various exercise prices, vesting dates and expiry dates.

●     2,443,413 unlisted $0.025 options expiring on 30 April 2026

Number acquired ●     11,091,950 IHL Ordinary Shares
Number disposed ●     11,091,950 IHL Ordinary Shares

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 $887,356
No. of securities held after change

●     36, 651 198 IHL Ordinary Shares

●      2,800,000 Options with various exercise prices, vesting dates and expiry dates.

●      2,443,413 unlisted $0.025 options expiring on 30 April 2026

 

+ See chapter 19 for defined terms. 
  
01/01/2011 Appendix 3Y  Page 1

 

 

Appendix 3Y

Change of Director’s Interest Notice 

 

 

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 Off Market Transfer

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract N/A
Nature of interest  

Name of registered holder

(if issued securities) 

  
Date of change  

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed 

  
Interest acquired  
Interest disposed  

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation 

  
Interest after change  

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No.
If so, was prior written clearance provided to allow the trade to proceed during this period?  
If prior written clearance was provided, on what date was this provided?  

 

+ See chapter 19 for defined terms. 
  
Appendix 3Y  Page 2

01/01/2011

 

 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Notes – Direct & Indirect Interests

 

(a) Description of entities/relationships:

 

1.Troy Valentine is:

 

a.A beneficiary of the GFCR Investments Trust, the FT Family Trust, and the Troy R Valentine Superfund;

 

b.A director of Tranaj Nominees Pty Ltd, Valplan Pty Ltd, Alignment Capital Pty Ltd and Cityside Pty Ltd

 

c.100% shareholder in Cityside Pty Ltd (ACN 112 375 354)(“Cityside”)

 

d.50% shareholder in Alignment Capital Pty Ltd (ACN 167 124 754)(“Alignment”)

 

2.Ekirtson Nominees Pty Ltd (ACN 137 521 825) is trustee for the GFCR Investments Trust (“Ekirtson”)

 

3.Tranaj Nominees Pty Ltd (ACN 137 521 843) is trustee of the FT Family Trust (“Tranaj”)

 

4.Valplan Pty Ltd (ACCN 135 269 169) is trustee of the Troy R Valentine Family Superfund (“Valplan”)

 

(b) Table 1 – holdings before changes

 

  IHL Ordinary Shares IHL Options
Troy Valentine 2,925,000^ 2,800,000^^
Ekirtson * 2,875,000  
Tranaj * 10,216,950  
Valplan 3,000,000  
Alignment * 13,194,248  
Cityside 4,440,000  
TOTAL 36,651,198  

 

(c) Table 2 – holdings after changes

 

  IHL Ordinary Shares IHL Options
Troy Valentine 2,925,000^ 2,994,999^^
Ekirtson * 1,000,000 191,667
Tranaj * 1,000,000 681,130
Valplan 3,000,000 200,000
Alignment * 24,286,198 879,617
Cityside 4,440,000 296,000
TOTAL 36,651,198  

 

*Mr Valentine is not the sole beneficiary of these entities.
^Of these 2,333,334 Securities issued to KMP as part of remuneration package for FY 21 and 22, subsequent to Shareholder Approval obtained at the General Meeting of the Company on 09 June 2022; with vesting dates as per details in the Notice of Meeting dated 12 May 2022. 466,666 Shares have already vested.
^^Securities issued to KMP as part of remuneration package for FY 21 and 22, subsequent to Shareholder Approval obtained at the General Meeting of the Company on 09 June 2022; with vesting dates as per details in the Notice of Meeting dated 12 May 2022.

 

+ See chapter 19 for defined terms. 
  
01/01/2011 Appendix 3Y  Page 3